Impact of Tumor Location on Postoperative Outcome of Intraductal Papillary Neoplasm of the Bile Duct
- 29 Downloads
The concept of intraductal papillary neoplasm of the bile duct (IPNB) has been proposed to be the biliary equivalent of intraductal papillary mucinous neoplasm (IPMN) of the pancreas. While the classification of IPMNs is based on their location of duct involvement, such classification has not been fully evaluated for IPNBs. The aim of this study is to investigate the value of IPNB classification based on its location.
A total of 306 consecutive patients who underwent surgical resection with a diagnosis of bile duct tumor were enrolled. Among these patients, 21 were diagnosed as having IPNB. The IPNBs were classified into two groups as follows: extrahepatic IPNB, which located in the distal or perihilar bile duct, and intrahepatic IPNB, which located more peripherally than the hilar bile duct. The clinicopathological features of the two groups were then compared.
Extrahepatic IPNB tended to show more invasive characteristics than intrahepatic IPNB (presence of invasive component: 40.0 vs. 9.1%, p = 0.084). Moreover, patients with extrahepatic IPNB showed significantly poorer relapse-free survival (RFS) than those with intrahepatic IPNB [5-year RFS rate (%): 81.8 vs. 16.2, p = 0.014].
Patients with intrahepatic IPNB show more favorable pathological characteristics and postoperative survival outcomes than those with extrahepatic IPNB.
Carbohydrate antigen 19-9
Intraductal papillary mucinous neoplasm of the pancreas
Intraductal papillary neoplasm of the bile duct
World Health Organization
Compliance with ethical standards
Conflict of interest
We have no conflicts of interest to declare.
Informed consent was obtained from all individual participants included in the study.
- 1.Bosman FT (2010) World Health Organization., international agency for research on cancer. WHO classification of tumours of the digestive system. Lyon, International agency for research on cancerGoogle Scholar
- 4.Nakanuma Y, Sato Y, Ojima H et al (2014) Clinicopathological characterization of so-called “cholangiocarcinoma with intraductal papillary growth” with respect to “intraductal papillary neoplasm of bile duct (IPNB)”. Int J Clin Exp Pathol 7:3112–3122Google Scholar
- 7.Adsay V, Mino-Kenudson M, Furukawa T et al (2016) Pathologic evaluation and reporting of intraductal papillary mucinous neoplasms of the pancreas and other tumoral intraepithelial neoplasms of pancreatobiliary tract: recommendations of verona consensus meeting. Ann Surg 263:162–177CrossRefGoogle Scholar
- 8.Ji Y, Fan J, Zhou J et al (2008) Intraductal papillary neoplasms of bile duct. A distinct entity like its counterpart in pancreas. Histol Histopathol 23:41–50Google Scholar
- 13.Union for International Cancer Control (UICC) TNM Classification of Malignant Tumors, Wiley Blackwell, New JerseyGoogle Scholar
- 16.Deutsch G, Jung J, Zheng M et al (2001) A bipotential precursor population for pancreas and liver within the embryonic endoderm. Development 128:871–881Google Scholar
- 19.Minagawa N, Sato N, Mori Y et al (2013) A comparison between intraductal papillary neoplasms of the biliary tract (BT-IPMNs) and intraductal papillary mucinous neoplasms of the pancreas (P-IPMNs) reveals distinct clinical manifestations and outcomes. Eur J Surg Oncol 39:554–558CrossRefGoogle Scholar
- 22.Fong Y, Blumgart LH (2000) Surgery of the liver and biliary tract. WB Saunders, PhiladelphiaGoogle Scholar